Welcome to our dedicated page for Aramark US SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Millions eat, heal, study, and cheer in venues run by Aramark. That reach translates into dense disclosures on food-cost inflation, long-term campus contracts, and the recent uniform-business spin-off. If you have ever searched for “Aramark insider trading Form 4 transactions” or wondered how a stadium caterer books revenue, you know the challenge: hundreds of pages, multiple exhibits, shifting segment names.
Stock Titan turns that sprawl into clarity. Our AI parses every 10-K and 10-Q the moment it hits EDGAR, flags labor-expense swings, and delivers a plain-English summary so “Aramark quarterly earnings report 10-Q filing” becomes a five-minute read. Need fast context on a surprise press release? We attach an “Aramark 8-K material events explained” card next to the source PDF. Real-time alerts surface “Aramark Form 4 insider transactions” so you can see when executives adjust holdings before new contract wins. Even the proxy—searchable under “Aramark proxy statement executive compensation”—is distilled to show incentive targets tied to food-service margins.
Everything is in one feed, updated instantly: annual report 10-K simplified, earnings report filing analysis, executive stock transactions Form 4, shelf registrations, and governance charters. Use it to compare segment performance across campuses and healthcare, monitor commodity-price hedges, or simply save hours understanding Aramark SEC documents with AI. Complex operations, explained simply—so you can focus on decisions, not document hunts.
John J. Zillmer, Director and Chief Executive Officer of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025 of 721.338 shares of Aramark common stock at a reported price of $0. After the transaction the filing lists 832,546.749 shares beneficially owned by the reporting person. The filing states these shares represent dividend equivalent rights that accrued on restricted stock units and vest on the same schedule as the underlying awards.
The Form 4 was signed by an attorney‑in‑fact on 08/21/2025. No cash purchase price was reported because the grant reflects dividend equivalents tied to existing restricted stock units rather than an open‑market purchase or sale.
Greg Creed, a director of Aramark (ARMK), reported a Form 4 disclosing awards that vested on 08/20/2025. The filing records the acquisition of 155.111 dividend equivalent rights related to deferred stock units at a $0 price. Following the transaction, the reporting person beneficially owns 58,282.323 shares directly and 12,475 shares indirectly through a trust. The filing explains these amounts represent dividend equivalents that vest on the same schedule as the underlying deferred stock units.
Karen Marie King, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The filing shows 29.912 shares were acquired at $0 as dividend equivalent rights credited on deferred stock units; these rights vest on the same schedule as the underlying awards. After the transaction, the reporting person beneficially owned 37,614.967 shares directly. The report was signed by an attorney‑in‑fact on 08/21/2025.
Bridgette P. Heller, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The Form 4 shows 79.515 shares acquired at $0, recorded as dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. Following the reported transaction, the filing lists 30,416.4 shares beneficially owned in a direct form. The filing was submitted by one reporting person and signed by an attorney‑in‑fact on 08/21/2025. The report includes the reporter's address at Aramark's Philadelphia office.
Patricia E. Lopez, a director of Aramark (ARMK), acquired 62.2 shares on 08/20/2025 through dividend equivalent rights that vested on deferred stock units she holds. The reported transaction shows a $0 per-share price and leaves the reporting person with 23,792.883 shares beneficially owned in a direct form. The filing clarifies these were dividend equivalent rights tied to the issuer's quarterly dividend and that such rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Kevin Wills, a director of Aramark (ARMK), reported a Form 4 filing showing an internal award-related acquisition dated 08/20/2025. The filing states 29.129 shares were acquired at $0 as dividend equivalent rights that accrued on deferred stock units held by the reporting person. After the reported transaction the filing shows the reporting person beneficially owning 16,696.312 shares. The filing explains these dividend equivalent rights vest on the same schedule as the underlying awards and were reported by an attorney-in-fact on 08/21/2025.
Stephen I. Sadove, a director of Aramark (ARMK), reported an internal transaction dated 08/20/2025 showing acquisition of 210.525 dividend-equivalent rights related to deferred stock units at a $0 price. After the transaction he beneficially owned 94,042.121 shares directly and 15,000 shares indirectly through a trust. The filing explains these dividend-equivalent rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Susan M. Cameron, a director of Aramark (ARMK), reported a non‑derivative acquisition of 111.956 shares on 08/20/2025. The filing states these shares represent dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. The reported per‑share price is $0, and following the transaction the reporting person beneficially owns 42,825.523 shares. The Form 4 was signed by an attorney‑in‑fact on 08/21/2025.
Brian M. DelGhiaccio, a director of Aramark (ARMK), reports a small acquisition tied to dividend-equivalent rights. The reporting person was credited with 29.129 shares as dividend equivalents on deferred stock units that vest on the same schedule as the underlying awards, and the transaction is recorded as an acquisition at no cash cost. After the credit, the reporting person beneficially owns 11,142.312 shares. The reported transaction date is 08/20/2025. The Form 4 shows this filing was submitted by an attorney-in-fact on behalf of the reporting person.
Richard W. Dreiling, a director of Aramark (ARMK), received dividend-equivalent rights that converted to 18.645 shares on 08/20/2025 at no cost to him. After the transaction he beneficially owned 6,267.292 shares. The filing states these dividend-equivalent rights accrued on deferred stock units and vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
FAQ
What is the current stock price of Aramark US (ARMK)?
What is the market cap of Aramark US (ARMK)?
